title: FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.
abstract: BACKGROUND
  FoxM1 has been reported to be important in initiation and progression of various tumors. However, whether FoxM1 has any indication for prognosis in non-small cell lung cancer patients remains unclear.
  
  
  RESULTS
  In this study, FoxM1 expression in tumor cells was examined first by immunohistochemistry in 175 NSCLC specimens, the result of which showed that FoxM1 overexpression was significantly associated with positive smoking status (P = 0.001), poorer tissue differentiation (P = 0.0052), higher TNM stage (P<0.0001), lymph node metastasis (P<0.0001), advanced tumor stage (P<0.0001), and poorer prognosis (P<0.0001). Multivariable analysis showed that FoxM1 expression increased the hazard of death (hazard ratio, 1.899; 95% CI, 1.016-3.551). Furthermore, by various in vitro and in vivo experiments, we showed that targeted knockdown of FoxM1 expression could inhibit the migratory and invasive abilities of NSCLC cells, whereas enforced expression of FoxM1 could increased the invasion and migration of NSCLC cells. Finally, we found that one of the cellular mechanisms by which FoxM1 promotes tumor metastasis is through inducing epithelial-mesenchymal transition (EMT) program.
  
  
  CONCLUSIONS
  These results suggested that FoxM1 overexpression in tumor tissues is significantly associated with the poor prognosis of NSCLC patients through promoting tumor metastasis.
authors.affiliation: Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
authors.forename: Nuo
authors.initials: N
authors.lastname: Xu
authors.forename: Deshui
authors.initials: D
authors.lastname: Jia
authors.forename: Wenfeng
authors.initials: W
authors.lastname: Chen
authors.forename: Hao
authors.initials: H
authors.lastname: Wang
authors.forename: Fanglei
authors.initials: F
authors.lastname: Liu
authors.forename: Haiyan
authors.initials: H
authors.lastname: Ge
authors.forename: Xiaodan
authors.initials: X
authors.lastname: Zhu
authors.forename: Yuanlin
authors.initials: Y
authors.lastname: Song
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: David
authors.initials: D
authors.lastname: Zhang
authors.forename: Di
authors.initials: D
authors.lastname: Ge
authors.forename: Chunxue
authors.initials: C
authors.lastname: Bai
mesh_terms: D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism* / Q000401:mortality / Q000473:pathology*; D018450:Disease Progression; D058750:Epithelial-Mesenchymal Transition / Q000235:genetics; D005260:Female; D000072278:Forkhead Box Protein M1; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D055786:Gene Knockout Techniques; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis
chemical_list: C107585:FOXM1 protein, human; D000072278:Forkhead Box Protein M1; D051858:Forkhead Transcription Factors
references.citation: Clin Cancer Res. 2011 Apr 1;17(7):1924-34
references.pmid: 21325289
references.citation: J Thorac Oncol. 2011 Nov;6(11):1865-71
references.pmid: 21964529
references.citation: Clin Cancer Res. 2004 May 1;10(9):3110-6
references.pmid: 15131051
references.citation: Cancer Res. 2006 Apr 1;66(7):3593-602
references.pmid: 16585184
references.citation: PLoS One. 2009;4(4):e5401
references.pmid: 19404390
references.citation: Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4125-33
references.pmid: 15217949
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1845-51
references.pmid: 17855704
references.citation: Cancer Res. 2011 Jul 1;71(13):4329-33
references.pmid: 21712406
references.citation: Head Neck. 2007 Jun;29(6):564-72
references.pmid: 17252594
references.citation: Pancreas. 2012 May;41(4):629-35
references.pmid: 22249132
references.citation: Neoplasia. 2004 Nov-Dec;6(6):744-50
references.pmid: 15720800
references.citation: Br J Cancer. 2011 Dec 6;105(12):1885-93
references.pmid: 22068819
references.citation: J Natl Cancer Inst. 2004 Jun 16;96(12):900-1
references.pmid: 15199105
references.citation: EMBO Mol Med. 2011 Jan;3(1):21-34
references.pmid: 21204266
references.citation: Gut. 2009 May;58(5):679-87
references.pmid: 19136513
references.citation: Cancer Res. 2006 Apr 1;66(7):3386-91
references.pmid: 16585158
references.citation: Clin Cancer Res. 2008 Aug 1;14(15):4743-50
references.pmid: 18676743
references.citation: BMC Cancer. 2007 Apr 12;7:64
references.pmid: 17430594
references.citation: Zhonghua Yi Xue Za Zhi. 2009 Sep 15;89(34):2424-8
references.pmid: 20137699
references.citation: Oncogene. 2007 Sep 13;26(42):6212-9
references.pmid: 17404569
references.citation: J Clin Invest. 2009 Jun;119(6):1420-8
references.pmid: 19487818
references.citation: Hum Pathol. 2009 Apr;40(4):464-70
references.pmid: 19121844
references.citation: Int J Cancer. 2005 Aug 10;116(1):36-44
references.pmid: 15761868
references.citation: Cancer Res. 2006 Feb 15;66(4):2153-61
references.pmid: 16489016
references.citation: Cancer Lett. 2011 Jul 28;306(2):214-22
references.pmid: 21482449
references.citation: Cancer Res. 2011 Jan 1;71(1):40-50
references.pmid: 21199796
references.citation: Cell. 1991 Jan 25;64(2):327-36
references.pmid: 1703045
references.citation: Cancer Res. 2011 Nov 15;71(22):7061-70
references.pmid: 21975935
references.citation: Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):426-30
references.pmid: 21875482
references.citation: Clin Exp Metastasis. 2003;20(8):733-44
references.pmid: 14713107
references.citation: Cancer Metastasis Rev. 2009 Dec;28(3-4):335-44
references.pmid: 20012924
references.citation: Oncogene. 2010 May 20;29(20):2983-95
references.pmid: 20208560
references.citation: Science. 1982 Sep 10;217(4564):998-1003
references.pmid: 7112116
references.citation: Cancer. 2008 May 1;112(9):2088-100
references.pmid: 18327819
references.citation: J Am Soc Nephrol. 2005 Mar;16(3):646-57
references.pmid: 15677310
references.citation: J Popul Ther Clin Pharmacol. 2011;18(1):e1-9
references.pmid: 21289376
references.citation: Cancer Res. 2006 Feb 1;66(3):1712-20
references.pmid: 16452231
references.citation: FASEB J. 2006 Sep;20(11):1892-4
references.pmid: 16818469